← Leaderboards
Raphael Bueno
Brigham And Women'S Hospital
$7,330,479
Attributed
$8,114,963
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $704.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,114,963 · 6
By mechanism
R01$6,339,540 · 2
R33$1,004,193 · 1
R21$546,095 · 2
T32$225,135 · 1
Top collaborators
- Jayender Jagadeesan4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jayender Jagadeesan$5,180,225
- Gavin J Gordon$173,000
Others in their field
Top investigators on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Larry Arthur$195,389,208
- Norman Wolmark · Nsabp Foundation, Inc.$177,775,854
- Lawrence Corey · Fred Hutchinson Cancer Center$130,508,383
- Richard K. Wilson · Washington University$128,382,063
Research focus
Operative Surgical ProceduresTumorDiagnosisExcisionDiagnosticAlgorithmsGene ExpressionMesotheliomaClinical TrialsBaseMalignant NeoplasmsSpecimenCohortStagingBiopsyMalignant Pleural MesotheliomaPrognosticPathologyPleuralEnrollmentProspectiveBiopsy SpecimenMalignant Neoplasm Of LungStratification
Grant awards (26)
Lung Navigation System for Localizing and Resecting Nodules$367,829
R01 · FY2021 · EB
Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma$302,092
R01 · FY2021 · CA · contact PI
Lung Navigation System for Localizing and Resecting Nodules$402,750
R01 · FY2020 · EB
Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma$302,092
R01 · FY2020 · CA · contact PI
Lung Navigation System for Localizing and Resecting Nodules$402,750
R01 · FY2019 · EB
Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma$293,028
R01 · FY2019 · CA · contact PI
Lung Navigation System for Localizing and Resecting Nodules$395,640
R01 · FY2018 · EB
Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma$303,868
R01 · FY2018 · CA · contact PI
Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma$358,443
R01 · FY2017 · CA · contact PI
Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma$345,927
R01 · FY2015 · CA · contact PI
Advanced Training in Surgical Oncology$225,135
T32 · FY2015 · CA · contact PI
Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma$335,146
R01 · FY2014 · CA · contact PI
Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma$324,397
R01 · FY2013 · CA · contact PI
Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma$344,704
R01 · FY2012 · CA · contact PI
Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma$343,781
R01 · FY2011 · CA · contact PI
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma$301,617
R01 · FY2010 · CA · contact PI
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma$301,617
R01 · FY2009 · CA · contact PI
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma$301,617
R01 · FY2008 · CA · contact PI
Gene Ratio Based Prognosis in Mesothelioma$344,804
R33 · FY2007 · CA · contact PI
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma$301,617
R01 · FY2007 · CA · contact PI
Gene Ratio Based Prognosis in Mesothelioma$321,255
R33 · FY2006 · CA · contact PI
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma$310,625
R01 · FY2006 · CA · contact PI
Gene Ratio Based Prognosis in Mesothelioma$338,134
R33 · FY2005 · CA
Gene Ratios for Lung Cancer Detection and Prognosis$196,498
R21 · FY2004 · CA
Gene Ratio Based Prognosis in Mesothelioma$152,787
R21 · FY2004 · CA
Gene Ratios for Lung Cancer Detection and Prognosis$196,810
R21 · FY2003 · CA